Drugs / BMS-986460
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06877702 | Mar → Dec 2025 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 1 | NCT06067841 | Oct 2023 → Aug 2029 expected | prostate carcinoma | Bristol-Myers Squibb | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-986460 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06067841 ↗ |